Form 4: MetLife EVP & Chief Risk Officer, Marlene Debel, Executes Stock Options and Sells Shares

Marlene Debel, EVP & Chief Risk Officer at MetLife, exercised stock options and sold shares on December 13, 2024.

Summary

• Marlene Debel, an Executive Vice President and Chief Risk Officer at MetLife, executed stock options and sold shares on December 13, 2024.
• She exercised options to acquire 13,107 shares at $34.33 and 9,703 shares at $45.91.
• Following the exercise of these options, she sold 22,810 shares at a weighted average price of $82.8837, with prices ranging from $82.83 to $82.931.
• After these transactions, Ms. Debel directly owns 108,507 shares of MetLife stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions by an executive, with no positive or negative implications for the company's performance.

Industry Context

This is a routine filing related to executive compensation and stock transactions, common in publicly traded companies like MetLife. It reflects the standard practice of executives exercising vested stock options and selling shares.

Comparison to Industry Standards

• Executive stock option exercises and sales are a common practice across the financial services industry.
• Companies like Prudential, AIG, and Lincoln Financial also have executives who regularly exercise options and sell shares.
• The reported prices and volumes are within the typical range for such transactions at large financial institutions.
• The vesting schedules and option terms are also consistent with industry norms.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine executive stock transactions.
• There is no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

MetLife, Stock Options, Share Sale, Insider Trading, Form 4, Marlene Debel, Executive Compensation